Rumor: Sam Altman backs Pharia Health, transcranial magnetic stimulation (TMS) protocol startup

The company targets high-performing professionals, pairing FDA-cleared TMS with d-cycloserine and optional $200 per month maintenance sessions.

By · Published

Illustration of a Pharia Health transcranial magnetic stimulation device operating on a seated patient.

The company targets high-performing professionals, pairing FDA-cleared TMS with d-cycloserine and optional $200 per month maintenance sessions.